Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boston top stories
immunotherapy
6
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
cancer immunotherapy
glaxosmithkline
novartis
abeona therapeutics
acute myeloid leukemia
aimmune therapeutics
akcea therapeutics
autoimmune diseases
biotech ipos
What
roundup
bio
biotech
cancer
days
drug
market
new
abbvie’s
according
advantages
agency
ahead
aimmune
akcea
allergy
annual
approval
approved
arrival
ash
awarded
bar
barcelona
biofourmis
brings
bucks
cases
celebrate
centers
chance
cigarettes
clinical
companies
conference
control
corner
day
deaths
december's
Language
unset
6
×
Current search:
immunotherapy
×
unset
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone